0 Valutazioni

ID

42829

Descrizione

ODM derived from http://clinicaltrials.gov/show/NCT00502840

collegamento

http://clinicaltrials.gov/show/NCT00502840

Keywords

  1. 10/12/13 10/12/13 - Martin Dugas
  2. 17/09/21 17/09/21 -
Caricato su

17 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Eligibility NCT00502840 Rheumatoid Arthritis

    Eligibility

    1. StudyEvent: Eligibility
      1. Eligibility
    Einschlusskriterien
    Descrizione

    Einschlusskriterien

    Alias
    UMLS CUI 2011AA
    CL425202
    Alter 18 bis 75 Jahre
    Descrizione

    age 18 Years to 75 Years

    Tipo di dati

    boolean

    Alias
    UMLS CUI 2011AA
    C0001779
    SNOMED CT 2011_0131
    397669002
    adult patients with rheumatoid arthritis who participated in ML19070, and have completed the week 24 visit
    Descrizione

    adult patients with rheumatoid arthritis who participated in ML19070, and have completed the week 24 visit

    Tipo di dati

    boolean

    Alias
    UMLS CUI 2011AA
    C0700597
    SNOMED CT 2011_0131
    41847000
    UMLS CUI 2011AA
    C0003873
    SNOMED CT 2011_0131
    69896004
    MedDRA 14.1
    10039073
    ICD-10-CM Version 2010
    M06.9
    ICD-9-CM Version 2011
    714.0
    UMLS CUI 2011AA
    C0011900
    SNOMED CT 2011_0131
    439401001
    LOINC Version 232
    MTHU008876
    UMLS CUI 2011AA
    C0681850
    UMLS CUI 2011AA
    C0205197
    SNOMED CT 2011_0131
    255594003
    UMLS CUI 2011AA
    C0585339
    SNOMED CT 2011_0131
    396149002
    UMLS CUI 2011AA
    C1512346
    HL7 V3 2006_05
    ENC
    eligible for re-treatment (DAS28 >2.6 after week 24, swollen joint count >=4, tender joint count >=4).
    Descrizione

    eligible for re-treatment (DAS28 >2.6 after week 24, swollen joint count >=4, tender joint count >=4).

    Tipo di dati

    boolean

    Alias
    UMLS CUI 2011AA
    C1302261
    SNOMED CT 2011_0131
    399223003
    UMLS CUI 2011AA
    C0376495
    UMLS CUI 2011AA
    C2711347
    SNOMED CT 2011_0131
    441870009
    UMLS CUI 2011AA
    C0231290
    SNOMED CT 2011_0131
    237679004
    UMLS CUI 2011AA
    C2825407
    UMLS CUI 2011AA
    C0439234
    SNOMED CT 2011_0131
    258707000
    HL7 V3 2006_05
    Y
    UMLS CUI 2011AA
    C0451521
    SNOMED CT 2011_0131
    273856009
    UMLS CUI 2011AA
    C0451530
    SNOMED CT 2011_0131
    273865002
    Ausschlusskriterien
    Descrizione

    Ausschlusskriterien

    Alias
    UMLS CUI 2011AA
    CL425201
    patients who have withdrawn from treatment in ML19070 pre-week 16
    Descrizione

    patients who have withdrawn from treatment in ML19070 pre-week 16

    Tipo di dati

    boolean

    Alias
    UMLS CUI 2011AA
    C0422727
    SNOMED CT 2011_0131
    185924006
    UMLS CUI 2011AA
    C2349954
    UMLS CUI 2011AA
    C0039798
    patients with a previous response in DAS28 <0.6 to MabThera after week 16
    Descrizione

    patients with a previous response in DAS28 <0.6 to MabThera after week 16

    Tipo di dati

    boolean

    Alias
    UMLS CUI 2011AA
    C0205156
    SNOMED CT 2011_0131
    9130008
    UMLS CUI 2011AA
    C0521982
    SNOMED CT 2011_0131
    182985004
    UMLS CUI 2011AA
    C2711347
    SNOMED CT 2011_0131
    441870009
    UMLS CUI 2011AA
    C0732355
    SNOMED CT 2011_0131
    386919002
    UMLS CUI 2011AA
    C0231290
    SNOMED CT 2011_0131
    237679004
    concurrent treatment with any DMARD except for methotrexate, any TNF alpha inhibitor, or other biologic or investigational agent.
    Descrizione

    concurrent treatment with any DMARD except for methotrexate, any TNF alpha inhibitor, or other biologic or investigational agent.

    Tipo di dati

    boolean

    Alias
    UMLS CUI 2011AA
    C0009429
    UMLS CUI 2011AA
    C0242708
    UMLS CUI 2011AA
    C1456820
    SNOMED CT 2011_0131
    39525005
    LOINC Version 232
    MTHU004497
    UMLS CUI 2011AA
    C1554961
    UMLS CUI 2011AA
    C0025677
    SNOMED CT 2011_0131
    387381009
    LOINC Version 232
    MTHU005020
    UMLS CUI 2011AA
    C1562242
    SNOMED CT 2011_0131
    420693002
    UMLS CUI 2011AA
    C0005522
    SNOMED CT 2011_0131
    418980009
    UMLS CUI 2011AA
    C0013230

    Similar models

    Eligibility

    1. StudyEvent: Eligibility
      1. Eligibility
    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    Einschlusskriterien
    CL425202 (UMLS CUI 2011AA)
    age 18 Years to 75 Years
    Item
    Alter 18 bis 75 Jahre
    boolean
    C0001779 (UMLS CUI 2011AA)
    397669002 (SNOMED CT 2011_0131)
    adult patients with rheumatoid arthritis who participated in ML19070, and have completed the week 24 visit
    Item
    adult patients with rheumatoid arthritis who participated in ML19070, and have completed the week 24 visit
    boolean
    C0700597 (UMLS CUI 2011AA)
    41847000 (SNOMED CT 2011_0131)
    C0003873 (UMLS CUI 2011AA)
    69896004 (SNOMED CT 2011_0131)
    10039073 (MedDRA 14.1)
    M06.9 (ICD-10-CM Version 2010)
    714.0 (ICD-9-CM Version 2011)
    C0011900 (UMLS CUI 2011AA)
    439401001 (SNOMED CT 2011_0131)
    MTHU008876 (LOINC Version 232)
    C0681850 (UMLS CUI 2011AA)
    C0205197 (UMLS CUI 2011AA)
    255594003 (SNOMED CT 2011_0131)
    C0585339 (UMLS CUI 2011AA)
    396149002 (SNOMED CT 2011_0131)
    C1512346 (UMLS CUI 2011AA)
    ENC (HL7 V3 2006_05)
    eligible for re-treatment (DAS28 >2.6 after week 24, swollen joint count >=4, tender joint count >=4).
    Item
    eligible for re-treatment (DAS28 >2.6 after week 24, swollen joint count >=4, tender joint count >=4).
    boolean
    C1302261 (UMLS CUI 2011AA)
    399223003 (SNOMED CT 2011_0131)
    C0376495 (UMLS CUI 2011AA)
    C2711347 (UMLS CUI 2011AA)
    441870009 (SNOMED CT 2011_0131)
    C0231290 (UMLS CUI 2011AA)
    237679004 (SNOMED CT 2011_0131)
    C2825407 (UMLS CUI 2011AA)
    C0439234 (UMLS CUI 2011AA)
    258707000 (SNOMED CT 2011_0131)
    Y (HL7 V3 2006_05)
    C0451521 (UMLS CUI 2011AA)
    273856009 (SNOMED CT 2011_0131)
    C0451530 (UMLS CUI 2011AA)
    273865002 (SNOMED CT 2011_0131)
    Item Group
    Ausschlusskriterien
    CL425201 (UMLS CUI 2011AA)
    patients who have withdrawn from treatment in ML19070 pre-week 16
    Item
    patients who have withdrawn from treatment in ML19070 pre-week 16
    boolean
    C0422727 (UMLS CUI 2011AA)
    185924006 (SNOMED CT 2011_0131)
    C2349954 (UMLS CUI 2011AA)
    C0039798 (UMLS CUI 2011AA)
    patients with a previous response in DAS28 <0.6 to MabThera after week 16
    Item
    patients with a previous response in DAS28 <0.6 to MabThera after week 16
    boolean
    C0205156 (UMLS CUI 2011AA)
    9130008 (SNOMED CT 2011_0131)
    C0521982 (UMLS CUI 2011AA)
    182985004 (SNOMED CT 2011_0131)
    C2711347 (UMLS CUI 2011AA)
    441870009 (SNOMED CT 2011_0131)
    C0732355 (UMLS CUI 2011AA)
    386919002 (SNOMED CT 2011_0131)
    C0231290 (UMLS CUI 2011AA)
    237679004 (SNOMED CT 2011_0131)
    concurrent treatment with any DMARD except for methotrexate, any TNF alpha inhibitor, or other biologic or investigational agent.
    Item
    concurrent treatment with any DMARD except for methotrexate, any TNF alpha inhibitor, or other biologic or investigational agent.
    boolean
    C0009429 (UMLS CUI 2011AA)
    C0242708 (UMLS CUI 2011AA)
    C1456820 (UMLS CUI 2011AA)
    39525005 (SNOMED CT 2011_0131)
    MTHU004497 (LOINC Version 232)
    C1554961 (UMLS CUI 2011AA)
    C0025677 (UMLS CUI 2011AA)
    387381009 (SNOMED CT 2011_0131)
    MTHU005020 (LOINC Version 232)
    C1562242 (UMLS CUI 2011AA)
    420693002 (SNOMED CT 2011_0131)
    C0005522 (UMLS CUI 2011AA)
    418980009 (SNOMED CT 2011_0131)
    C0013230 (UMLS CUI 2011AA)

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial